125 related articles for article (PubMed ID: 7424559)
41. Spiral computed tomography of the liver: contrast agent pharmacokinetics and the potential for improved hepatic enhancement.
Polger M; Seltzer SE; Head BL; Savci G; Silverman SG; Adams DF
Acad Radiol; 1995 Jan; 2(1):19-25. PubMed ID: 9419519
[TBL] [Abstract][Full Text] [Related]
42. Contrast dose for enhancement of computed tomograms of the brain.
Paling MR
Br J Radiol; 1979 Aug; 52(620):620-3. PubMed ID: 486891
[TBL] [Abstract][Full Text] [Related]
43. Computed tomographic enhancement of liver and spleen in the dog with iodipamide ethyl ester particulate suspensions.
Sands MS; Violante MR; Gadeholt G
Invest Radiol; 1987 May; 22(5):408-16. PubMed ID: 3597009
[TBL] [Abstract][Full Text] [Related]
44. Intravenous contrast enhancement in computed tomography of pelvic malignancies.
Burgener FA; Hamlin DJ
Rofo; 1981 Jun; 134(6):656-61. PubMed ID: 6454627
[TBL] [Abstract][Full Text] [Related]
45. High contrast enhancement of the liver in CT by repeated doses of contrast medium.
Rossi P; Rovighi L; Tipaldi L; Bompiani C; Simonetti G
Eur J Radiol; 1981 May; 1(2):126-31. PubMed ID: 7338235
[TBL] [Abstract][Full Text] [Related]
46. [Modern X-ray contrast media applicable to intravenous cholangiocholecystography (review of the literature)].
Sviridov NK; Popova ZP; Varfolomeeva VN; Mikhaĭlova NA
Farmakol Toksikol; 1981; 44(2):245-7. PubMed ID: 7023971
[No Abstract] [Full Text] [Related]
47. Release of serotonin from human platelets in vitro by radiographic contrast media.
Ring J; Sovak M
Invest Radiol; 1981; 16(3):245-8. PubMed ID: 7053228
[TBL] [Abstract][Full Text] [Related]
48. Aberrant right posterior biliary duct: detection by intravenous cholangiography with helical CT.
Murakami T; Kim T; Tomoda K; Narumi Y; Sakon M; Monden M; Nakamura H
J Comput Assist Tomogr; 1997; 21(5):733-4. PubMed ID: 9294563
[No Abstract] [Full Text] [Related]
49. Iodine removal in intravenous dual-energy CT-cholangiography: is virtual non-enhanced imaging effective to replace true non-enhanced imaging?
Sommer CM; Schwarzwaelder CB; Stiller W; Schindera ST; Stampfl U; Bellemann N; Holzschuh M; Schmidt J; Weitz J; Grenacher L; Kauczor HU; Radeleff BA
Eur J Radiol; 2012 Apr; 81(4):692-9. PubMed ID: 21353419
[TBL] [Abstract][Full Text] [Related]
50. Hepatic enhancement and metastatic lesion conspicuity on CT scans: influence of intravenous glucagon and oral CT contrast material.
Warshauer DM; Wehmueller MD; Molina PL; Muller KE; DeLuca MC; Lee JK
Radiology; 1997 Feb; 202(2):394-8. PubMed ID: 9015064
[TBL] [Abstract][Full Text] [Related]
51. Gd-EOB-DTPA and Yb-EOB-DTPA: two prototypic contrast media for CT detection of liver lesions in dogs.
Schmitz SA; Wagner S; Schuhmann-Giampieri G; Krause W; Bollow M; Wolf KJ
Radiology; 1997 Nov; 205(2):361-6. PubMed ID: 9356615
[TBL] [Abstract][Full Text] [Related]
52. ["Static" and dynamic contrast enhancement of the trunk--computer tomography (author's transl)].
Hübener KH; Klott KJ
Rofo; 1980 Oct; 133(4):347-54. PubMed ID: 6453761
[TBL] [Abstract][Full Text] [Related]
53. Dynamic CT of hepatic masses with intravenous and intraarterial contrast material.
Moss AA; Dean PB; Axel L; Goldberg HI; Glazer GM; Friedman MA
AJR Am J Roentgenol; 1982 May; 138(5):847-52. PubMed ID: 6282093
[TBL] [Abstract][Full Text] [Related]
54. Dual-energy, standard and low-kVp contrast-enhanced CT-cholangiography: a comparative analysis of image quality and radiation exposure.
Stiller W; Schwarzwaelder CB; Sommer CM; Veloza S; Radeleff BA; Kauczor HU
Eur J Radiol; 2012 Jul; 81(7):1405-12. PubMed ID: 21458939
[TBL] [Abstract][Full Text] [Related]
55. [A technique of infusion of contrast material on CT enhancement study (author's transl)].
Munemitsu H; Matsuda M; Hirai O; Kawamura J; Matsubayashi K; Fukuyama H; Fukumitsu T
Nihon Geka Hokan; 1980 Mar; 49(2):195-200. PubMed ID: 7387318
[No Abstract] [Full Text] [Related]
56. [Comparison of the side effects of urographic contrast media (iothalamate, diatrizoate, iodamide, iopamidol) within the scope of a CT study].
Stellamor K; Hruby W; Assinger S; Luckner H
Radiologe; 1984 Oct; 24(10):488-90. PubMed ID: 6505221
[TBL] [Abstract][Full Text] [Related]
57. Cranial CT revisited: do we really need contrast enhancement?
Demaerel P; Buelens C; Wilms G; Baert AL
Eur Radiol; 1998; 8(8):1447-51. PubMed ID: 9853234
[TBL] [Abstract][Full Text] [Related]
58. [Experimental hepatosplenography after the administration of liposomes with verografin].
Aliiakparov MT; Rozenberg OA; Fomina EV; Loshakova LV; Gubareva AV
Med Radiol (Mosk); 1981 Nov; 26(11):45-8. PubMed ID: 7321787
[No Abstract] [Full Text] [Related]
59. Renal excretion mechanism of a nonionic contrast agent.
Golman K; Wilk I
Invest Radiol; 1979; 14(3):224-7. PubMed ID: 468494
[TBL] [Abstract][Full Text] [Related]
60. Contrast enhancement dynamic CT measurements and a mathematical model.
Cassel DM; Young SW; Turner R
Invest Radiol; 1982; 17(1):82-9. PubMed ID: 7076440
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
